Thermo Fisher Scientific Inc. $TMO Shares Bought by Quantitative Investment Management LLC

Quantitative Investment Management LLC raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 230.5% in the third quarter, Holdings Channel.com reports. The institutional investor owned 9,361 shares of the medical research company’s stock after purchasing an additional 6,529 shares during the quarter. Quantitative Investment Management LLC’s holdings in Thermo Fisher Scientific were worth $4,540,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Thermo Fisher Scientific by 4.6% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,266,125 shares of the medical research company’s stock worth $614,096,000 after purchasing an additional 55,171 shares during the last quarter. Invesco Ltd. lifted its position in Thermo Fisher Scientific by 22.8% during the third quarter. Invesco Ltd. now owns 1,915,286 shares of the medical research company’s stock worth $928,952,000 after buying an additional 355,659 shares in the last quarter. Seven Mile Advisory boosted its stake in Thermo Fisher Scientific by 46.6% during the third quarter. Seven Mile Advisory now owns 871 shares of the medical research company’s stock worth $422,000 after buying an additional 277 shares during the last quarter. Douglass Winthrop Advisors LLC grew its holdings in Thermo Fisher Scientific by 3.5% in the 3rd quarter. Douglass Winthrop Advisors LLC now owns 25,207 shares of the medical research company’s stock valued at $12,226,000 after buying an additional 851 shares in the last quarter. Finally, SevenBridge Financial Group LLC increased its stake in shares of Thermo Fisher Scientific by 21.8% in the 3rd quarter. SevenBridge Financial Group LLC now owns 6,034 shares of the medical research company’s stock worth $2,927,000 after acquiring an additional 1,079 shares during the last quarter. 89.23% of the stock is owned by hedge funds and other institutional investors.

Thermo Fisher Scientific Price Performance

TMO stock opened at $475.78 on Friday. The business’s fifty day moving average price is $560.39 and its 200 day moving average price is $548.36. Thermo Fisher Scientific Inc. has a 12-month low of $385.46 and a 12-month high of $643.99. The company has a current ratio of 1.89, a quick ratio of 1.53 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $176.74 billion, a PE ratio of 26.82, a P/E/G ratio of 2.86 and a beta of 0.96.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Thursday, January 29th. The medical research company reported $6.57 earnings per share for the quarter, beating the consensus estimate of $6.45 by $0.12. The company had revenue of $12.22 billion during the quarter, compared to the consensus estimate of $11.95 billion. Thermo Fisher Scientific had a return on equity of 16.92% and a net margin of 15.05%.Thermo Fisher Scientific’s revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the company posted $6.10 EPS. On average, sell-side analysts anticipate that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.

Thermo Fisher Scientific Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Friday, March 13th will be paid a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Friday, March 13th. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.43. Thermo Fisher Scientific’s payout ratio is currently 9.70%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on TMO. Robert W. Baird set a $653.00 price target on shares of Thermo Fisher Scientific in a research report on Friday, January 30th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Thermo Fisher Scientific in a research note on Friday, January 9th. Barclays increased their price target on shares of Thermo Fisher Scientific from $625.00 to $650.00 and gave the company an “overweight” rating in a research note on Friday, January 30th. Evercore restated an “outperform” rating and set a $650.00 price target on shares of Thermo Fisher Scientific in a report on Monday, January 5th. Finally, Stifel Nicolaus upped their price objective on Thermo Fisher Scientific from $583.00 to $700.00 and gave the company a “buy” rating in a report on Friday, January 9th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, Thermo Fisher Scientific currently has a consensus rating of “Moderate Buy” and an average price target of $633.68.

Insider Buying and Selling

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 5,000 shares of the stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $512.40, for a total transaction of $2,562,000.00. Following the sale, the chief executive officer directly owned 123,925 shares in the company, valued at $63,499,170. This represents a 3.88% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Gianluca Pettiti sold 400 shares of the business’s stock in a transaction on Monday, February 9th. The stock was sold at an average price of $541.20, for a total transaction of $216,480.00. Following the completion of the transaction, the executive vice president owned 20,752 shares of the company’s stock, valued at approximately $11,230,982.40. This trade represents a 1.89% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.33% of the stock is owned by corporate insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.